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Myocardial Viability
The major reason why a clinical cardiologist pursues myocardial
viability is to reduce cardiovascular mortality. Although there are no
data about it, the rationale basis is the preservation of ventricular
function by the identification of reversible regional myocardial dys-
function, leading to a lower risk of death, assuming that the better the
ejection fraction the lower the mortality. The problem rests on the
risk/benefit ratio. The risk is to revascularize through bypass surgery or
coronary angioplasty, taking into account clinical condition, inherent
procedural complications, mortality and restenosis rates. In the case of
coronary angioplasty, low flow conditions may lead to hybernating
myocardium. There are widely available data about myocardial viabil-
ity but none answering the question of how much viable myocardium
is worth justifying the risk of the revascularization procedure and a
significant increase in ejection fraction. It seems that we have a long
way to go because the accepted documentation of viable myocardium
is made just after revascularization, and there is no “gold standard”
method for predicting reversibility of contractile dysfunction. Elhendy
et al. (1) in a recent issue of the Journal observed that 14 patients with
reversible single-photon emission computed tomographic imaging
perfusion defects had no evidence of myocardial ischemia as assessed
by wall motion abnormalities on stress echocardiography with dobut-
amine infusion, a finding commented on by Wackers (2). But in this
group of patients, four (28.5%) showed improvement of contraction in
the infarcted region, a finding that should be interpreted as an evidence of
ischemia if we accept the idea that all ischemic myocardium is viable
myocardium. In addition, all patients had documented coronary artery
disease (diameter stenosis .50%), leading to the hypothesis that im-
provement of wall motion abnormalities observed in the infarct area is
consistent with the presence of hibernating myocardium.
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Reply
We thank Shibata for his interesting remarks on our study of patients
with dobutamine-induced hypoperfusion without transient wall motion
abnormalities (1). Among the 14 patients without transient wall
motion abnormalities in our study, reversible perfusion defects were
confined to dyssynergic segments in 4 (29%). However, only two of
these four patients showed improved wall thickening at low dose
dobutamine. Improvement was maintained at high dose. These pa-
tients were not considered to have ischemia at echocardiography
because we used the standard criteria of new or worsening wall motion
abnormalities to define an ischemic response. As Shibata points out,
myocardial ischemia should also be considered in the presence of
evidence of myocardial viability, as in the case of improvement of a
dyssynergic segment during low dose dobutamine infusion. Although
myocardial ischemia and hibernation are related phenomena, we did
not consider the improvement at low dose dobutamine as a definite
ischemic response because we have shown (2) that only akinetic
segments with a biphasic response to dobutamine have a relatively high
prevalence of reversible thallium defects (51% vs. 9% of segments with
persistent improvement, p , 0.005) as well as a higher prevalence of
functional improvement (3) after revascularization (79% vs. 30% of
segments with persistent improvement, p , 0.005). It is possible that in
our study (1), the low rate-pressure product in the group without
transient wall motion abnormalities did not allow for the occurrence of
a biphasic response, and consequently, dyssynergic segments showed a
persistent improvement rather than a biphasic response. This obser-
vation supports our recommendation that every effort showed be made
to attain a high rate-pressure product to elicit myocardial ischemia at
dobutamine echocardiography. The conclusion of our study was that
the absence of transient wall motion abnormalities in patients with
reversible perfusion defects does not imply less severe ischemia but is
associated with a lower rate-pressure product. Inclusion of patients
with a previous myocardial infarction in our study did not seem to limit
our conclusion because we have recently demonstrated (4) that in
patients with infarct-related artery stenosis, the prevalence of peri-
infarction ischemia at dobutamine stress echocardiography, using the
standard criteria of new or worsening wall motion abnormalities, is not
significantly different from the prevalence of ischemia according to
reversible hypoperfusion on simultaneous 2-methoxy isobutyl isonitrile
(MIBI) single-photon emission computed tomography (4).
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Increased Neopterin in Patients With
Chronic and Acute Coronary Syndromes
I read with interest the report by Schumacher et al. (1) regarding
plasma neopterin levels in acute and chronic coronary syndromes.
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